Anti-RNF2 antibody produced in rabbit

RING finger protein 2 (RNF2), also known as RNF1b, consists of 336 amino acids and it belongs to PcG (polycomb-group) protein family. This protein is encoded by the gene mapped on human chromosome 1q25.3. The encoded protein is characterized with a unique C3HC4 RING finger motif.

ring finger protein 2 recombinant protein epitope signature tag (PrEST)

All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported by the most extensive characterization in the industry.

The Human Protein Atlas project can be subdivided into three efforts: Human Tissue Atlas, Cancer Atlas, and Human Cell Atlas. The antibodies that have been generated in support of the Tissue and Cancer Atlas projects have been tested by immunohistochemistry against hundreds of normal and disease tissues and through the recent efforts of the Human Cell Atlas project, many have been characterized by immunofluorescence to map the human proteome not only at the tissue level but now at the subcellular level. These images and the collection of this vast data set can be viewed on the Human Protein Atlas (HPA) site by clicking on the Image Gallery link. We also provide Prestige Antibodies^® protocols and other useful information.

RING finger protein 2 (RNF2), in association with prohibitin, regulates the activity of E2F transcription factor 1(E2F1) by the direct, prohibitin-mediated pathway and the indirect, p16-mediated pathway. Rnf2 might act as a vital assembly factor in PRC (Polycomb repressive complex), which is required for mammalian development. Decrease in the expression of Rnf2 or ring1b causes gastrulation arrest and cell cycle inhibition. Overexpression of RNF2 results in pathogenesis of urothelial carcinoma of the bladder (UCB). RNF2 interacts with E2 ubiquitin-conjugating enzymes and display E3 ubiquitin ligase activity. RNF2 plays a crucial role in cancer cell survival and proliferation, therefore it can serve as a potential therapeutic target for cancer treatment and prevention.

Prestige Antibodies^® are highly characterized and extensively validated antibodies with the added benefit of all available characterization data for each target being accessible via the Human Protein Atlas portal linked just below the product name at the top of this page. The uniqueness and low cross-reactivity of the Prestige Antibodies^® to other proteins are due to a thorough selection of antigen regions, affinity purification, and stringent selection. Prestige antigen controls are available for every corresponding Prestige Antibody and can be found in the linkage section.

Every Prestige Antibody is tested in the following ways:

• IHC tissue array of 44 normal human tissues and 20 of the most common cancer type tissues.
• Protein array of 364 human recombinant protein fragments.

Corresponding Antigen APREST71062

Solution in phosphate-buffered saline, pH 7.2, containing 40% glycerol and 0.02% sodium azide.

Prestige Antibodies is a registered trademark of Merck KGaA, Darmstadt, Germany

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.